國立虎尾科技大學 |

Drug wars : = how big pharma raises prices and keeps generics off the market /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drug wars :/ Robin Feldman, Evan Frondorf.
Reminder of title:	how big pharma raises prices and keeps generics off the market /
Author:	Feldman, Robin,
other author:	Frondorf, Evan,
Description:	1 online resource (xii, 151 pages) :digital, PDF file(s). :
Notes:	Title from publisher's bibliographic system (viewed on 17 Jul 2017).
Subject:	Drugs - Prices - United States. -
Online resource:	https://doi.org/10.1017/9781316717424
ISBN:	9781316717424 (ebook)

Drug wars : = how big pharma raises prices and keeps generics off the market /
Feldman, Robin,

Drug wars :how big pharma raises prices and keeps generics off the market /Robin Feldman, Evan Frondorf. - 1 online resource (xii, 151 pages) :digital, PDF file(s).

Title from publisher's bibliographic system (viewed on 17 Jul 2017).

Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform.

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.

ISBN: 9781316717424 (ebook)Subjects--Topical Terms:

1029752
Drugs
--Prices--United States.

LC Class. No.: RA401.A3 / F45 2017

Dewey Class. No.: 338.4/76151

Drug wars : = how big pharma raises prices and keeps generics off the market /
LDR:02384nam a22003018i 4500 001 1122709
003 UkCbUP
005 20170814135646.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 240926s2017||||enk o ||1 0|eng|d
020 $a 9781316717424 (ebook)
020 $z 9781107168480 (hardback)
035 $a CR9781316717424
040 $a UkCbUP $b eng $e rda $c UkCbUP
043 $a n-us---
050 0 0 $a RA401.A3 $b F45 2017
082 0 0 $a 338.4/76151 $2 23
100 1 $a Feldman, Robin, $e author. $3 1439114
245 1 0 $a Drug wars : $b how big pharma raises prices and keeps generics off the market / $c Robin Feldman, Evan Frondorf.
264 1 $a Cambridge : $b Cambridge University Press, $c 2017.
300 $a 1 online resource (xii, 151 pages) : $b digital, PDF file(s).
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Title from publisher's bibliographic system (viewed on 17 Jul 2017).
505 8 $a Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform.
520 $a While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
650 0 $a Drugs $x Prices $z United States. $3 1029752
650 0 $a Drugs $x Law and legislation $z United States. $3 570576
650 0 $a Pharmaceutical policy $z United States. $3 1005584
650 0 $a Pharmaceutical industry $z United States. $3 583249
650 0 $a Generic drugs $z United States. $3 1294173
700 1 $a Frondorf, Evan, $e author. $3 1439115
776 0 8 $i Print version: $z 9781107168480
856 4 0 $u https://doi.org/10.1017/9781316717424